Evidence to Practice @evi2prac

We bring new evidence from clinical trials to the clinical community via educational activities, enabling informed uptake of new treatments and best practice. e2p.com.au Melbourne, Victoria Joined September 2018

Tweets

205
Followers

105
Following

125
Likes

98

The Asia Pacific Cardiometabolic Consortium @the_apcmc

a year ago

Congratulations to our member @WannJiaLoh for hosting a Lp(a) #Awareness Day in conjunction with Changi General Hospital (CGH). Her goal was to 'unpack the who, what, why and how's of #lipoprotein(a).' Find out more information about Dr Wann’s initiative apcmc.net/education/

0 2 6 307 0

Download Image

The Asia Pacific Cardiometabolic Consortium @the_apcmc

3 years ago

This Thursday, 16th March at 8.00pm AEDT via @apsc_office @ProfSNicholls will summarise the results from the CLEAR Outcomes trial. Join Steve and our panel as we discuss this important trial and the new option it presents for patients with statin intolerance.

1 3 6 380 0

Download Image

Evidence to Practice @evi2prac

3 years ago

Join us at our annual Symposium to discuss the latest topical and developing areas in cardiology! Tickets are going fast so register today.

0 0 0 80 0

Download Image

Evidence to Practice @evi2prac

3 years ago

The INVICTUS study showing that in RHD-AF, compared to rivaroxaban,VKAs have a lower mortality and reduced ischemic stroke without increasing the risk of major bleeding. VKAs should remain the standard of care in RHD-AF

0 2 5 0 0

Download Image

NEJM @NEJM

3 years ago

DELIVER: In an RCT involving patients with HF and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the risk of the composite outcome of worsening heart failure or CV death. #ESCCongress nej.md/3PJ6Oir